Please use this identifier to cite or link to this item:
|Title:||PD-L1 alternative splicing||Authors:||Zhen, Yashu||Keywords:||Science::Biological sciences||Issue Date:||2022||Publisher:||Nanyang Technological University||Source:||Zhen, Y. (2022). PD-L1 alternative splicing. Doctoral thesis, Nanyang Technological University, Singapore. https://hdl.handle.net/10356/156429||Project:||AcRF Tier 1 RG25/19(S)||Abstract:||PD-L1 is an immune checkpoint molecule which is upregulated in some tumors to evade the immune response. Generation of truncated and nonfunctional PD-L1 variants by modulation of alternative splicing presents a novel strategy for cancer treatments. PD-L1 alternative splicing was studied using minigenes, to identify a splicing silencer inside Exon 4 exonic intron (exitron) which represses the splicing of this exitron. Besides, this splicing event seems to require the 5’ss splice site of Exon 4, and it is also negatively regulated by SRSF1 and the 3’ss splice site of Exon 6.||URI:||https://hdl.handle.net/10356/156429||Rights:||This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||SBS Theses|
Updated on May 16, 2022
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.